Clinical Data

Professor Robertson's laboratory and OncImmune® have run clinical investigations using prototype measurements since 1998. These experimental studies, run in an iterative fashion to find optimal conditions for cancer early detection, have provided a wealth of unique clinical data indicating the ability of properly developed assays to detect cancer earlier than other known methodology.